Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publication and briefly summarized - that is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 4/2023

Edition 3/2023

Edition 2/2023

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn’s disease: A GETAID multicenter cohort study

Aliment Pharmacol Ther. 2023;57(4):426–34

Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn’s disease

Clin Gastroenterol Hepatol. 2023;21(1):153–63.e12

Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: When the remission state hides different types of residual disease activity

Gut. 2023;72(3):443–50

Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: Systematic review and network meta-analysis

Gut. 2023;72(2):264–74

Top-down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease

Inflamm Bowel Dis. 2023;29(2):185–94

Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): A prospective, multicenter cohort study

Lancet Gastroenterol Hepatol. 2023;8(1):31–42

Rapid and sustained symptom relief in patients with ulcerative colitis treated with filgotinib: Data from the phase 2b/3 SELECTION trial

Am J Gastroenterol. 2023;118(1):138–47

Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF-experienced ulcerative colitis patients: A nationwide Dutch Registry study

Clin Gastroenterol Hepatol. 2023;21(1):182–91.e2

Early management of acute severe UC in the biologics era: Development and international validation of a prognostic clinical index to predict steroid response

Gut. 2023;72(3):433–42